Gut microbiome and CAR-T therapy
Abstract Considerable progress has been made in cancer therapeutics recently with targeted strategies that are efficacious and less toxic. Immunotherapy and chimeric antigen receptor (CAR) T-cells are increasingly being evaluated in a variety of tumors in the relapsed/refractory as well as frontline...
Main Authors: | Muhammad Bilal Abid, Nirav N. Shah, Theresa C. Maatman, Parameswaran N. Hari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40164-019-0155-8 |
Similar Items
-
Could the menagerie of the gut microbiome really cure cancer? Hope or hype
by: Muhammad Bilal Abid
Published: (2019-04-01) -
Gut Microbiome Modulation for Preventing and Treating Pediatric Food Allergies
by: Margherita Di Costanzo, et al.
Published: (2020-07-01) -
Psoriasis and Gut Microbiome—Current State of Art
by: Karina Polak, et al.
Published: (2021-04-01) -
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
by: Nirav N. Shah, et al.
Published: (2019-03-01) -
Marsupial Gut Microbiome
by: Rowena Chong, et al.
Published: (2020-05-01)